The most inhibitory Tregs express excess TNFR2, which plays a critical role in the activation and expansion of Tregs, on their surfaces in human cancers (Govindaraj et al., 2013; Govindaraj et al., 2014; Liao et al., 2023). This evidence concerns the gene TNFRSF1B and cancer.